• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Protein Cell . Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy

tetano

Editor, Senior Moderator
Protein Cell


. 2024 Mar 5:pwae006.
doi: 10.1093/procel/pwae006. Online ahead of print. Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy

Chenxiang Xi[SUP] 1 [/SUP], Zihui Yan[SUP] 1 [/SUP], Dandan Bai[SUP] 1 2 [/SUP], Yalin Zhang[SUP] 1 [/SUP], Beiying Wang[SUP] 1 [/SUP], Xiao Xiao Han[SUP] 1 [/SUP], Li Wu[SUP] 1 [/SUP], Xiaohui Shi[SUP] 1 [/SUP], Zhiyi Hu[SUP] 1 [/SUP], Ming Tang[SUP] 1 [/SUP], Zhongqu Su[SUP] 1 [/SUP], Yingdong Liu[SUP] 1 [/SUP], Binya Liu[SUP] 1 [/SUP], Jiqing Yin[SUP] 1 [/SUP], Hong Wang[SUP] 1 [/SUP], Xiaocui Li[SUP] 1 [/SUP], Yanping Zhang[SUP] 1 [/SUP], Shaorong Gao[SUP] 1 [/SUP], Wenqiang Liu[SUP] 1 [/SUP]



Affiliations
Free article Abstract

The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) remains a threat to pregnant women. However, the impact of early pregnancy SARS-CoV-2 infection on the maternal-fetal interface remains poorly understood. Here, we present a comprehensive analysis of single-cell transcriptomics and metabolomics in placental samples infected with SARS-CoV-2 during early pregnancy. Compared to control placentas, SARS-CoV-2 infection elicited immune responses at the maternal-fetal interface and induced metabolic alterations in amino acid and phospholipid profiles during the initial weeks post infection. However, subsequent immune cell activation and heightened immune tolerance in trophoblast cells established a novel dynamic equilibrium that mitigated the impact on the maternal-fetal interface. Notably, the immune response and metabolic alterations at the maternal-fetal interface exhibited a gradual decline during the second-trimester. Our study underscores the adaptive immune tolerance mechanisms and establishment of immunological balance during the first two trimesters following maternal SARS-CoV-2 infection.

Keywords: SARS; fetal; immune; interface; maternal; rebalancing.

 
Back
Top Bottom